B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	Coherence
I-Diagnostic_tool	18	28	Tomography
B-Symptom	29	39	Reflective
I-Symptom	40	46	Drusen
I-Symptom	47	60	Substructures
O	61	68	Predict
O	69	80	Progression
O	81	83	to
B-Symptom	84	94	Geographic
I-Symptom	95	102	Atrophy
O	103	105	in
B-Disease	106	109	Age
I-Disease	109	110	-
I-Disease	110	117	related
I-Disease	118	125	Macular
I-Disease	126	138	Degeneration
O	138	139	.

O	141	151	Structural
O	152	155	and
O	156	169	compositional
O	170	183	heterogeneity
O	184	190	within
B-Symptom	191	197	drusen
O	198	208	comprising
O	209	215	lipids
O	215	216	,
O	217	230	carbohydrates
O	230	231	,
O	232	235	and
O	236	244	proteins
O	245	249	have
O	250	254	been
O	255	265	previously
O	266	275	described
O	275	276	.

O	277	279	We
O	280	286	sought
O	287	289	to
O	290	296	detect
O	297	300	and
O	301	307	define
O	308	318	phenotypic
O	319	327	patterns
O	328	330	of
B-Symptom	331	337	drusen
O	338	351	heterogeneity
O	352	354	in
O	355	358	the
O	359	363	form
O	364	366	of
B-Diagnostic_tool	367	374	optical
I-Diagnostic_tool	375	384	coherence
I-Diagnostic_tool	385	395	tomography
O	395	396	-
B-Symptom	396	406	reflective
I-Symptom	407	413	drusen
I-Symptom	414	427	substructures
O	428	429	(
B-Symptom	429	432	ODS
O	432	433	)
O	434	437	and
O	438	445	examine
O	446	451	their
O	452	464	associations
O	465	469	with
B-Disease	470	473	age
I-Disease	473	474	-
I-Disease	474	481	related
I-Disease	482	489	macular
I-Disease	490	502	degeneration
O	503	504	(
B-Disease	504	507	AMD
O	507	508	)
O	508	509	-
O	509	516	related
O	517	525	features
O	526	529	and
B-Disease	530	533	AMD
O	534	545	progression
O	545	546	.

O	547	560	Retrospective
O	561	569	analysis
O	570	572	in
O	573	574	a
O	575	586	prospective
O	587	592	study
O	592	593	.

O	594	602	Patients
O	603	607	with
B-Disease	608	620	intermediate
I-Disease	621	624	AMD
O	625	626	(
O	626	627	n
O	628	629	=
O	630	633	349
O	633	634	)
O	635	643	enrolled
O	644	646	in
O	647	650	the
O	651	662	multicenter
O	663	666	Age
O	666	667	-
O	667	674	Related
B-Anatomy	675	678	Eye
O	679	686	Disease
O	687	692	Study
O	693	694	2
O	695	696	(
O	696	702	AREDS2
O	702	703	)
O	704	713	ancillary
B-Diagnostic_tool	714	722	spectral
I-Diagnostic_tool	722	723	-
I-Diagnostic_tool	723	729	domain
I-Diagnostic_tool	730	737	optical
I-Diagnostic_tool	738	747	coherence
I-Diagnostic_tool	748	758	tomography
O	759	760	(
B-Diagnostic_tool	760	762	SD
I-Diagnostic_tool	763	766	OCT
O	766	767	)
O	768	773	study
O	773	774	.

O	775	783	Baseline
B-Diagnostic_tool	784	786	SD
I-Diagnostic_tool	787	790	OCT
O	791	796	scans
O	797	799	of
O	800	801	1
B-Anatomy	802	805	eye
O	806	809	per
O	810	817	patient
O	818	822	were
O	823	831	analyzed
O	832	835	for
O	836	839	the
O	840	848	presence
O	849	851	of
B-Symptom	852	855	ODS
O	855	856	.

O	857	862	Cross
O	862	863	-
O	863	872	sectional
O	873	876	and
O	877	889	longitudinal
O	890	902	associations
O	903	905	of
B-Symptom	906	909	ODS
O	910	918	presence
O	919	923	with
B-Disease	924	927	AMD
O	927	928	-
O	928	935	related
O	936	944	features
O	945	952	visible
O	953	955	on
B-Diagnostic_tool	956	958	SD
I-Diagnostic_tool	959	962	OCT
O	963	966	and
B-Diagnostic_tool	967	972	color
I-Diagnostic_tool	973	984	photographs
O	984	985	,
O	986	995	including
B-Characteristic	996	1002	drusen
I-Characteristic	1003	1009	volume
O	1009	1010	,
B-Symptom	1011	1021	geographic
I-Symptom	1022	1029	atrophy
O	1030	1031	(
B-Symptom	1031	1033	GA
O	1033	1034	)
O	1034	1035	,
O	1036	1039	and
B-Characteristic	1040	1051	preatrophic
I-Characteristic	1052	1060	features
O	1060	1061	,
O	1062	1066	were
O	1067	1076	evaluated
O	1077	1080	for
O	1081	1084	the
O	1085	1091	entire
B-Anatomy	1092	1099	macular
O	1100	1106	region
O	1106	1107	.

O	1108	1115	Similar
O	1116	1128	associations
O	1129	1133	were
O	1134	1138	also
O	1139	1143	made
O	1144	1151	locally
O	1152	1158	within
O	1159	1160	a
O	1161	1162	0
O	1162	1163	.
O	1163	1164	5
O	1164	1165	-
O	1165	1167	mm
O	1167	1168	-
O	1168	1176	diameter
O	1177	1183	region
O	1184	1190	around
O	1191	1201	individual
B-Symptom	1202	1205	ODS
O	1206	1209	and
O	1210	1223	corresponding
O	1224	1231	control
O	1232	1238	region
O	1239	1246	without
B-Symptom	1247	1250	ODS
O	1251	1253	in
O	1254	1257	the
O	1258	1262	same
B-Anatomy	1263	1266	eye
O	1266	1267	.

B-Symptom	1268	1278	Preatrophy
I-Symptom	1279	1281	SD
I-Symptom	1282	1285	OCT
I-Symptom	1286	1293	changes
O	1294	1297	and
B-Symptom	1298	1300	GA
O	1300	1301	,
B-Symptom	1302	1309	central
I-Symptom	1310	1312	GA
O	1312	1313	,
O	1314	1317	and
B-Symptom	1318	1327	choroidal
I-Symptom	1328	1346	neovascularization
O	1347	1348	(
B-Symptom	1348	1351	CNV
O	1351	1352	)
O	1353	1357	from
B-Diagnostic_tool	1358	1363	color
I-Diagnostic_tool	1364	1375	photographs
O	1375	1376	.

O	1377	1381	Four
O	1382	1392	phenotypic
O	1393	1401	subtypes
O	1402	1404	of
B-Symptom	1405	1408	ODS
O	1409	1413	were
O	1414	1421	defined
O	1421	1422	:
B-Symptom	1423	1426	low
I-Symptom	1427	1437	reflective
I-Symptom	1438	1443	cores
O	1443	1444	,
B-Symptom	1445	1449	high
I-Symptom	1450	1460	reflective
I-Symptom	1461	1466	cores
O	1466	1467	,
B-Symptom	1468	1475	conical
I-Symptom	1476	1482	debris
O	1482	1483	,
O	1484	1487	and
B-Symptom	1488	1493	split
I-Symptom	1494	1500	drusen
O	1500	1501	.

O	1502	1507	Among
O	1508	1511	the
O	1512	1515	349
O	1516	1528	participants
O	1528	1529	,
O	1530	1535	there
O	1536	1540	were
O	1541	1544	307
O	1545	1553	eligible
B-Anatomy	1554	1558	eyes
O	1559	1562	and
O	1563	1565	74
O	1566	1567	(
O	1567	1569	24
O	1569	1570	%
O	1570	1571	)
O	1572	1575	had
O	1576	1578	at
O	1579	1584	least
O	1585	1586	1
B-Symptom	1587	1590	ODS
O	1590	1591	.

O	1592	1595	The
B-Symptom	1596	1599	ODS
O	1600	1602	at
O	1603	1611	baseline
O	1612	1616	were
O	1617	1627	associated
O	1628	1632	with
O	1633	1634	(
O	1634	1635	1
O	1635	1636	)
O	1637	1644	greater
B-Symptom	1645	1652	macular
I-Symptom	1653	1659	drusen
O	1660	1666	volume
O	1667	1669	at
O	1670	1678	baseline
O	1679	1680	(
O	1680	1681	P
O	1683	1684	<
O	1686	1687	0
O	1687	1688	.
O	1688	1691	001
O	1691	1692	)
O	1692	1693	,
O	1694	1695	(
O	1695	1696	2
O	1696	1697	)
O	1698	1709	development
O	1710	1712	of
B-Symptom	1713	1724	preatrophic
I-Symptom	1725	1732	changes
O	1733	1735	at
O	1736	1740	year
O	1741	1742	2
O	1743	1744	(
O	1744	1745	P
O	1746	1747	=
O	1748	1749	0
O	1749	1750	.
O	1750	1753	001
O	1753	1754	-
O	1754	1755	0
O	1755	1756	.
O	1756	1758	01
O	1758	1759	)
O	1759	1760	,
O	1761	1764	and
O	1765	1766	(
O	1766	1767	3
O	1767	1768	)
O	1769	1780	development
O	1781	1783	of
B-Symptom	1784	1791	macular
I-Symptom	1792	1794	GA
O	1795	1796	(
O	1796	1797	P
O	1798	1799	=
O	1800	1801	0
O	1801	1802	.
O	1802	1805	005
O	1805	1806	)
O	1807	1810	and
B-Symptom	1811	1822	preatrophic
I-Symptom	1823	1830	changes
O	1831	1833	at
O	1834	1838	year
O	1839	1840	3
O	1841	1842	(
O	1842	1843	P
O	1844	1845	=
O	1846	1847	0
O	1847	1848	.
O	1848	1851	002
O	1851	1852	-
O	1852	1853	0
O	1853	1854	.
O	1854	1857	008
O	1857	1858	)
O	1858	1859	,
O	1860	1863	but
O	1864	1867	not
O	1868	1879	development
O	1880	1882	of
B-Symptom	1883	1886	CNV
O	1886	1887	.

O	1888	1891	The
B-Symptom	1892	1895	ODS
O	1896	1898	at
O	1899	1907	baseline
O	1908	1910	in
O	1911	1912	a
O	1913	1918	local
O	1919	1925	region
O	1926	1930	were
O	1931	1941	associated
O	1942	1946	with
O	1947	1948	(
O	1948	1949	1
O	1949	1950	)
O	1951	1959	presence
O	1960	1962	of
B-Symptom	1963	1973	preatrophy
I-Symptom	1974	1981	changes
O	1982	1984	at
O	1985	1993	baseline
O	1994	1995	(
O	1995	1996	P
O	1997	1998	=
O	1999	2000	0
O	2000	2001	.
O	2001	2003	02
O	2003	2004	-
O	2004	2005	0
O	2005	2006	.
O	2006	2008	03
O	2008	2009	)
O	2010	2013	and
O	2014	2015	(
O	2015	2016	2
O	2016	2017	)
O	2018	2029	development
O	2030	2032	of
B-Symptom	2033	2043	preatrophy
I-Symptom	2044	2051	changes
O	2052	2054	at
O	2055	2060	years
O	2061	2062	2
O	2063	2066	and
O	2067	2068	3
O	2069	2075	within
O	2076	2079	the
O	2080	2086	region
O	2087	2088	(
O	2088	2089	P
O	2090	2091	=
O	2092	2093	0
O	2093	2094	.
O	2094	2097	008
O	2097	2098	-
O	2098	2099	0
O	2099	2100	.
O	2100	2102	05
O	2102	2103	)
O	2103	2104	.

B-Diagnostic_tool	2105	2112	Optical
I-Diagnostic_tool	2113	2122	coherence
I-Diagnostic_tool	2123	2133	tomography
O	2133	2134	-
B-Symptom	2134	2144	reflective
I-Symptom	2145	2151	drusen
I-Symptom	2152	2165	substructures
O	2166	2169	are
B-Diagnostic_tool	2170	2177	optical
I-Diagnostic_tool	2178	2187	coherence
I-Diagnostic_tool	2188	2198	tomography
O	2198	2199	-
O	2199	2204	based
O	2205	2215	biomarkers
O	2216	2218	of
O	2219	2230	progression
O	2231	2233	to
B-Symptom	2234	2236	GA
O	2236	2237	,
O	2238	2241	but
O	2242	2245	not
O	2246	2248	to
B-Symptom	2249	2252	CNV
O	2252	2253	,
O	2254	2256	in
B-Anatomy	2257	2261	eyes
O	2262	2266	with
B-Disease	2267	2279	intermediate
I-Disease	2280	2283	AMD
O	2283	2284	.

B-Diagnostic_tool	2285	2292	Optical
I-Diagnostic_tool	2293	2302	coherence
I-Diagnostic_tool	2303	2313	tomography
O	2313	2314	-
B-Symptom	2314	2324	reflective
I-Symptom	2325	2331	drusen
I-Symptom	2332	2345	substructures
O	2346	2349	may
O	2350	2352	be
O	2353	2354	a
O	2355	2363	clinical
O	2364	2370	entity
O	2371	2378	helpful
O	2379	2381	in
O	2382	2392	monitoring
B-Disease	2393	2396	AMD
O	2397	2408	progression
O	2409	2412	and
O	2413	2422	informing
O	2423	2433	mechanisms
O	2434	2436	in
B-Symptom	2437	2439	GA
O	2440	2452	pathogenesis
O	2452	2453	.
